SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-18-298490
Filing Date
2018-10-12
Accepted
2018-10-12 17:29:43
Documents
8
Effectiveness Date
2018-10-12

Document Format Files

Seq Description Document Type Size
1 S-3ASR d624372ds3asr.htm S-3ASR 540485
2 EX-1.2 d624372dex12.htm EX-1.2 189139
3 EX-4.4 d624372dex44.htm EX-4.4 253948
4 EX-4.5 d624372dex45.htm EX-4.5 263206
5 EX-5.1 d624372dex51.htm EX-5.1 13982
6 EX-5.2 d624372dex52.htm EX-5.2 7256
7 EX-23.1 d624372dex231.htm EX-23.1 1936
8 GRAPHIC g624372g57j37.jpg GRAPHIC 33539
  Complete submission text file 0001193125-18-298490.txt   1317201
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-227814 | Film No.: 181120881
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences